US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 51.228
  • +0.828+1.64%
Trading Dec 4 10:40 ET
1.96BMarket Cap-13660P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
73.26%-8.65M
39.55%-14.4M
-72.00%-37.79M
-139.63%-117.49M
-261.73%-39.34M
-73.89%-32.36M
-459.43%-23.83M
-43.73%-21.97M
-1,408.16%-49.03M
10.29%-10.87M
Net income from continuing operations
40.18%-23.42M
-5.94%-33.29M
-52.57%-35.73M
-118.86%-135.89M
-208.13%-41.9M
-73.91%-39.15M
-447.17%-31.42M
-15.72%-23.42M
-349.06%-62.09M
8.43%-13.6M
Operating gains losses
-93.92%9K
16,786.67%2.53M
509.09%201K
-123.31%-117K
-1,741.18%-313K
722.22%148K
-94.12%15K
-86.59%33K
-52.42%502K
92.70%-17K
Depreciation and amortization
16.39%284K
31.32%239K
159.62%270K
169.85%877K
254.08%347K
159.57%244K
97.83%182K
153.66%104K
4.17%325K
145.00%98K
Other non cash items
30.97%296K
16.81%264K
6.03%246K
19.79%926K
21.61%242K
7.11%226K
15.90%226K
38.10%232K
-86.65%773K
71.55%199K
Change In working capital
462.85%7.91M
229.12%10.25M
-510.45%-8.59M
132.18%306K
-3,402.35%-2.81M
3,093.18%1.41M
214.90%3.12M
-186.27%-1.41M
-169.31%-951K
129.73%85K
-Change in receivables
108.75%536K
-80.49%521K
-2,152.18%-13.65M
-304.90%-14.13M
-2,744.06%-11.34M
-80.54%-6.12M
1,037.19%2.67M
374.79%665K
-4,680.82%-3.49M
832.61%429K
-Change in inventory
-4,246.67%-652K
---692K
---929K
---3.11M
---3.09M
---15K
--0
--0
--0
--0
-Change in prepaid assets
-44.89%-1.15M
255.89%767K
314.40%1.07M
-300.69%-2.89M
-46.31%-1.86M
-198.51%-793K
58.31%-492K
-72.25%257K
64.71%-721K
7.83%-1.27M
-Change in payables and accrued expense
8.83%9.15M
507.95%9.17M
313.99%5.05M
491.93%20.97M
1,163.90%13.41M
219.13%8.41M
233.66%1.51M
-341.70%-2.36M
-37.18%3.54M
16.72%1.06M
-Change in other current assets
124.51%25K
188.79%483K
178.95%106K
-233.95%-718K
21.43%-110K
---102K
-511.24%-544K
171.43%38K
90.51%-215K
-128.17%-140K
-Change in other current liabilities
--0
96.55%-1K
-2,800.00%-232K
376.12%185K
2,600.00%189K
1,200.00%33K
-3.57%-29K
81.40%-8K
-158.26%-67K
120.00%7K
Cash from discontinued investing activities
Operating cash flow
73.26%-8.65M
39.55%-14.4M
-72.00%-37.79M
-139.63%-117.49M
-261.73%-39.34M
-73.89%-32.36M
-459.43%-23.83M
-43.73%-21.97M
-1,408.16%-49.03M
10.29%-10.87M
Investing cash flow
Cash flow from continuing investing activities
-93.40%3.13M
-163.23%-40.53M
-1,005.12%-102.22M
197.22%140.6M
120.47%17.85M
182.92%47.37M
52,634.43%64.09M
7,114.91%11.29M
-24,580.72%-144.63M
-31,731.75%-87.22M
Net PPE purchase and sale
24.80%-282K
-32.02%-1.04M
48.82%-174K
-196.84%-1.5M
--0
-290.63%-375K
-545.08%-787K
-111.18%-340K
13.65%-506K
53.65%-127K
Net intangibles purchase and sale
----
----
----
---4M
--0
----
----
----
--0
--0
Net investment purchase and sale
-93.41%3.41M
-160.86%-39.49M
-977.17%-102.05M
201.38%146.11M
120.50%17.85M
190.73%51.74M
--64.88M
--11.63M
---144.12M
---87.09M
Cash from discontinued investing activities
Investing cash flow
-93.40%3.13M
-163.23%-40.53M
-1,005.12%-102.22M
197.22%140.6M
120.47%17.85M
182.92%47.37M
52,634.43%64.09M
7,114.91%11.29M
-24,580.72%-144.63M
-31,731.75%-87.22M
Financing cash flow
Cash flow from continuing financing activities
-99.39%639K
8,197.84%42.32M
2,069.78%108.77M
38.50%130.18M
7,384.85%19.76M
77,227.21%104.89M
-99.32%510K
-73.79%5.01M
447,457.14%93.99M
456.76%264K
Net issuance payments of debt
--0
--75M
--0
-50.00%10M
--0
--5M
--0
-75.00%5M
--20M
--0
Net common stock issuance
-100.04%-43K
---9.64M
--107.97M
59.51%118.6M
--19.22M
45,685.78%99.38M
--0
--0
--74.35M
--0
Proceeds from stock option exercised by employees
1,854.65%10.09M
479.22%2.95M
6,069.23%802K
169.57%1.58M
103.79%538K
529.27%516K
113.39%510K
--13K
80.56%585K
15.28%264K
Net other financing activities
---39K
----
----
----
----
----
----
----
-213.53%-950K
--0
Cash from discontinued financing activities
Financing cash flow
-99.39%639K
8,197.84%42.32M
2,069.78%108.77M
38.50%130.18M
7,384.85%19.76M
77,227.21%104.89M
-99.32%510K
-73.79%5.01M
447,457.14%93.99M
456.76%264K
Net cash flow
Beginning cash position
69.61%181.1M
193.51%193.71M
213.91%224.95M
-58.17%71.66M
33.74%226.67M
-56.48%106.77M
-62.29%66M
-58.17%71.66M
1.89%171.33M
-7.79%169.49M
Current changes in cash
-104.07%-4.89M
-130.93%-12.61M
-451.69%-31.24M
253.79%153.29M
98.24%-1.73M
258.02%119.9M
-42.04%40.78M
-253.97%-5.66M
-3,231.39%-99.67M
-684.58%-97.83M
End cash Position
-22.26%176.21M
69.61%181.1M
193.51%193.71M
213.91%224.95M
213.91%224.95M
33.74%226.67M
-56.48%106.77M
-62.29%66M
-58.17%71.66M
-58.17%71.66M
Free cash flow
75.68%-8.93M
37.26%-15.44M
-70.16%-37.96M
-148.29%-123M
-257.56%-39.34M
-96.38%-36.74M
-461.81%-24.61M
-44.43%-22.31M
-1,666.60%-49.54M
11.25%-11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 73.26%-8.65M39.55%-14.4M-72.00%-37.79M-139.63%-117.49M-261.73%-39.34M-73.89%-32.36M-459.43%-23.83M-43.73%-21.97M-1,408.16%-49.03M10.29%-10.87M
Net income from continuing operations 40.18%-23.42M-5.94%-33.29M-52.57%-35.73M-118.86%-135.89M-208.13%-41.9M-73.91%-39.15M-447.17%-31.42M-15.72%-23.42M-349.06%-62.09M8.43%-13.6M
Operating gains losses -93.92%9K16,786.67%2.53M509.09%201K-123.31%-117K-1,741.18%-313K722.22%148K-94.12%15K-86.59%33K-52.42%502K92.70%-17K
Depreciation and amortization 16.39%284K31.32%239K159.62%270K169.85%877K254.08%347K159.57%244K97.83%182K153.66%104K4.17%325K145.00%98K
Other non cash items 30.97%296K16.81%264K6.03%246K19.79%926K21.61%242K7.11%226K15.90%226K38.10%232K-86.65%773K71.55%199K
Change In working capital 462.85%7.91M229.12%10.25M-510.45%-8.59M132.18%306K-3,402.35%-2.81M3,093.18%1.41M214.90%3.12M-186.27%-1.41M-169.31%-951K129.73%85K
-Change in receivables 108.75%536K-80.49%521K-2,152.18%-13.65M-304.90%-14.13M-2,744.06%-11.34M-80.54%-6.12M1,037.19%2.67M374.79%665K-4,680.82%-3.49M832.61%429K
-Change in inventory -4,246.67%-652K---692K---929K---3.11M---3.09M---15K--0--0--0--0
-Change in prepaid assets -44.89%-1.15M255.89%767K314.40%1.07M-300.69%-2.89M-46.31%-1.86M-198.51%-793K58.31%-492K-72.25%257K64.71%-721K7.83%-1.27M
-Change in payables and accrued expense 8.83%9.15M507.95%9.17M313.99%5.05M491.93%20.97M1,163.90%13.41M219.13%8.41M233.66%1.51M-341.70%-2.36M-37.18%3.54M16.72%1.06M
-Change in other current assets 124.51%25K188.79%483K178.95%106K-233.95%-718K21.43%-110K---102K-511.24%-544K171.43%38K90.51%-215K-128.17%-140K
-Change in other current liabilities --096.55%-1K-2,800.00%-232K376.12%185K2,600.00%189K1,200.00%33K-3.57%-29K81.40%-8K-158.26%-67K120.00%7K
Cash from discontinued investing activities
Operating cash flow 73.26%-8.65M39.55%-14.4M-72.00%-37.79M-139.63%-117.49M-261.73%-39.34M-73.89%-32.36M-459.43%-23.83M-43.73%-21.97M-1,408.16%-49.03M10.29%-10.87M
Investing cash flow
Cash flow from continuing investing activities -93.40%3.13M-163.23%-40.53M-1,005.12%-102.22M197.22%140.6M120.47%17.85M182.92%47.37M52,634.43%64.09M7,114.91%11.29M-24,580.72%-144.63M-31,731.75%-87.22M
Net PPE purchase and sale 24.80%-282K-32.02%-1.04M48.82%-174K-196.84%-1.5M--0-290.63%-375K-545.08%-787K-111.18%-340K13.65%-506K53.65%-127K
Net intangibles purchase and sale ---------------4M--0--------------0--0
Net investment purchase and sale -93.41%3.41M-160.86%-39.49M-977.17%-102.05M201.38%146.11M120.50%17.85M190.73%51.74M--64.88M--11.63M---144.12M---87.09M
Cash from discontinued investing activities
Investing cash flow -93.40%3.13M-163.23%-40.53M-1,005.12%-102.22M197.22%140.6M120.47%17.85M182.92%47.37M52,634.43%64.09M7,114.91%11.29M-24,580.72%-144.63M-31,731.75%-87.22M
Financing cash flow
Cash flow from continuing financing activities -99.39%639K8,197.84%42.32M2,069.78%108.77M38.50%130.18M7,384.85%19.76M77,227.21%104.89M-99.32%510K-73.79%5.01M447,457.14%93.99M456.76%264K
Net issuance payments of debt --0--75M--0-50.00%10M--0--5M--0-75.00%5M--20M--0
Net common stock issuance -100.04%-43K---9.64M--107.97M59.51%118.6M--19.22M45,685.78%99.38M--0--0--74.35M--0
Proceeds from stock option exercised by employees 1,854.65%10.09M479.22%2.95M6,069.23%802K169.57%1.58M103.79%538K529.27%516K113.39%510K--13K80.56%585K15.28%264K
Net other financing activities ---39K-----------------------------213.53%-950K--0
Cash from discontinued financing activities
Financing cash flow -99.39%639K8,197.84%42.32M2,069.78%108.77M38.50%130.18M7,384.85%19.76M77,227.21%104.89M-99.32%510K-73.79%5.01M447,457.14%93.99M456.76%264K
Net cash flow
Beginning cash position 69.61%181.1M193.51%193.71M213.91%224.95M-58.17%71.66M33.74%226.67M-56.48%106.77M-62.29%66M-58.17%71.66M1.89%171.33M-7.79%169.49M
Current changes in cash -104.07%-4.89M-130.93%-12.61M-451.69%-31.24M253.79%153.29M98.24%-1.73M258.02%119.9M-42.04%40.78M-253.97%-5.66M-3,231.39%-99.67M-684.58%-97.83M
End cash Position -22.26%176.21M69.61%181.1M193.51%193.71M213.91%224.95M213.91%224.95M33.74%226.67M-56.48%106.77M-62.29%66M-58.17%71.66M-58.17%71.66M
Free cash flow 75.68%-8.93M37.26%-15.44M-70.16%-37.96M-148.29%-123M-257.56%-39.34M-96.38%-36.74M-461.81%-24.61M-44.43%-22.31M-1,666.60%-49.54M11.25%-11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data